CIDRAP newsletters options
The comments prompted swift and sharp criticism among some public health experts.
"We think these principles can be applied to the next respiratory viral epidemic," a committee chair said of the SHEA statement.
In its weekly flu update on Sep 16, the Centers for Disease Control and Prevention (CDC) reported two more variant H1N2 (H1N2v) infections, in Michigan and Wisconsin.
About 9 months after COVID-19 infection, 19% of nonhospitalized adult patients in a German cohort had fatigue, 26% had mild cognitive impairment ("brain fog"), and 1% had moderate cognitive dysfunction, according to a multicenter study.
The study, published late last week in EClinicalMedicine, also showed that the incidence and risk factors for fatigue and cognitive impairment differed by age-group.
After 2 years, 12% had lingering symptoms and 8% had new-onset or worsening symptoms.
Zero of 313 exposed healthcare workers got monkeypox, even though only 23% wore adequate protective equipment.
One in three unvaccinated COVID-19 survivors in a Spanish cohort had no detectable SARS-CoV-2 antibodies nearly 1 year after infection, according to a prospective study published today in BMC Medicine.
An analysis of data on patients hospitalized with community-acquired pneumonia (CAP) found that extended-spectrum antibiotic therapy was associated with increased mortality compared with standard antibiotic therapy, Japanese researchers reported yesterday in the International Journal of Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
The report spares no one the responsibility—including the public—for millions of preventable deaths.
Few laboratories in sub-Saharan Africa conduct bacteriologic testing, and only a fraction of them can evaluate bacteria for antimicrobial resistance.
"As we implement the interventions that we have, simultaneously, we still pursue some unanswered questions."
South African researchers report waning monovalent (single-strain) COVID-19 vaccine booster effectiveness against the Omicron subvariants, with estimated efficacy falling to 50% against the BA.1/BA.2 and 47% against BA.4/BA.5 as early as 3 or 4 months after vaccination.
The Centers for Disease Control and Prevention (CDC) yesterday reported an Escherichia coli O157:H7 outbreak tied to Hello Fresh meal kits that contained contaminated ground beef.
In US news, practitioners describe issues with vaccination due to multiple vaccine products and confusing immunization schedules.
CDC Director Walensky says patients and clinicians likely did not recognize this new infection early on.
Older COVID-19 survivors may be at a 69% higher risk of developing Alzheimer's within 1 year.
SARS-CoV-2 antibodies fell over time after vaccination or COVID-19 infection but were restored with booster doses in West Virginia nursing home residents and staff, and antibody levels were significantly lower during the Delta than the Omicron variant surges in those with breakthrough infections, finds a study published yesterday in JAMA Network Open.
A second study shows a 41% reduction in long COVID among vaccinated people.
Two men in their 30s developed encephalomyelitis, or inflammation of the brain and spinal cord.
